Literature DB >> 1555658

Cyclosporin A-cyclophilin complex formation. A model based on X-ray and NMR data.

C Spitzfaden1, H P Weber, W Braun, J Kallen, G Wider, H Widmer, M D Walkinshaw, K Wüthrich.   

Abstract

The previously determined 3D NMR solution structure of cyclophilin-bound cyclosporin A (CsA) was docked onto the X-ray crystal structure of cyclophilin. Intermolecular nuclear Overhauser effects (NOE) between CsA and cyclophilin were used as constraints in a restrained energy minimization to generate a model of the complex which satisfied all the NOE distance constraints. The model shows that the residues 9 to 11 and 1 to 5 of the cyclic CsA molecule are in contact with cyclophilin. Comparing the model of the CsA-cyclophilin complex to the X-ray crystal structure of a complex of cyclophilin with a substrate for peptidyl-proline cis-trans isomerase activity, i.e. the linear tetrapeptide substrate ac-Ala-Ala-Pro-Ala-amc (ac, acetyl; amc, amidomethylcoumarin), one notices that the contacting peptide segments in the two ligands are oriented in opposite directions, and that the side chain of MeVal-11 of CsA superposes rather precisely with the position of the prolyl residue in ac-Ala-Ala-Pro-Ala-amc.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1555658     DOI: 10.1016/0014-5793(92)80866-f

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  13 in total

1.  Design criteria for molecular mimics of fragments of the beta-turn. 2. C alpha-C beta bond vector analysis.

Authors:  S L Garland; P M Dean
Journal:  J Comput Aided Mol Des       Date:  1999-09       Impact factor: 3.686

2.  A molecular dynamics study of Cyclophilin A free and in complex with the Ala-Pro dipeptide.

Authors:  Pekka Mark; Lennart Nilsson
Journal:  Eur Biophys J       Date:  2007-01-16       Impact factor: 1.733

3.  Identification of the immunophilins capable of mediating inhibition of signal transduction by cyclosporin A and FK506: roles of calcineurin binding and cellular location.

Authors:  R J Bram; D T Hung; P K Martin; S L Schreiber; G R Crabtree
Journal:  Mol Cell Biol       Date:  1993-08       Impact factor: 4.272

4.  Antibody variable region binding by Staphylococcal protein A: thermodynamic analysis and location of the Fv binding site on E-domain.

Authors:  M A Starovasnik; M P O'Connell; W J Fairbrother; R F Kelley
Journal:  Protein Sci       Date:  1999-07       Impact factor: 6.725

5.  Identification of critical residues in the colicin E9 DNase binding region of the Im9 protein.

Authors:  M J Osborne; R Wallis; K Y Leung; G Williams; L Y Lian; R James; C Kleanthous; G R Moore
Journal:  Biochem J       Date:  1997-05-01       Impact factor: 3.857

6.  Cyclophilin binding to the human immunodeficiency virus type 1 Gag polyprotein is mimicked by an anti-cyclosporine antibody.

Authors:  E K Franke; B X Chen; I Tatsis; A Diamanduros; B F Erlanger; J Luban
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

7.  A cyclophilin from the polycentric anaerobic rumen fungus Orpinomyces sp. strain PC-2 is highly homologous to vertebrate cyclophilin B.

Authors:  H Chen; X L Li; L G Ljungdahl
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

8.  X-ray structure of a cyclophilin B/cyclosporin complex: comparison with cyclophilin A and delineation of its calcineurin-binding domain.

Authors:  V Mikol; J Kallen; M D Walkinshaw
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

Review 9.  Getting in shape: controlling peptide bioactivity and bioavailability using conformational constraints.

Authors:  Jonathan E Bock; Jason Gavenonis; Joshua A Kritzer
Journal:  ACS Chem Biol       Date:  2012-11-30       Impact factor: 5.100

10.  E9-Im9 colicin DNase-immunity protein biomolecular association in water: a multiple-copy and accelerated molecular dynamics simulation study.

Authors:  Riccardo Baron; Sergio E Wong; Cesar A F de Oliveira; J Andrew McCammon
Journal:  J Phys Chem B       Date:  2008-12-25       Impact factor: 2.991

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.